Trade Summary

6 days ago, KUMAR AMIT, serving as Chief Executive Officer at Anixa Biosciences Inc (ANIX), purchased 21,000 shares at $2.50 per share, for a total transaction value of $52,500.00. Following this transaction, KUMAR AMIT now holds 630,812 shares of ANIX.

This purchase represents a 3.44% increase in KUMAR AMIT's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 9:00 AM ET, 4 days after the trade was made.

Anixa Biosciences Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.